Atlas Trials

KRAS p.G12C Mutant Advanced Solid Tumors

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch KRAS p.G12C Mutant Advanced Solid Tumors

RecordFirmDate
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) (NCT03600883)Amgen2018-08-27

Track KRAS p.G12C Mutant Advanced Solid Tumors automatically

Every clearance here is in the API, with alerts when new ones post.